Ladera Ranch, CA, United States of America

Alec D Lebsack

USPTO Granted Patents = 25 

 

 

Average Co-Inventor Count = 9.4

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • San Diego, CA (US) (2010 - 2014)
  • Ladera Ranch, CA (US) (2015 - 2023)

Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):

Title: **Alec D. Lebsack: Innovator in Pharmaceutical Compounds**

Introduction

Alec D. Lebsack, based in Ladera Ranch, California, is a notable inventor in the field of pharmaceuticals. With an impressive portfolio of 25 patents, Lebsack has made significant contributions to the development of small molecule inhibitors aimed at treating various diseases. His work focuses primarily on innovative approaches to tackling serious health conditions, making him a key figure in the biomedical research arena.

Latest Patents

Among his latest inventions, Lebsack has developed small molecule inhibitors of NF-κB inducing kinase. These compounds are designed to inhibit NIK and are coupled with pharmaceutical compositions which aim to prevent or treat diseases such as cancer, particularly B-cell malignancies including leukemias, lymphomas, and myeloma. Additionally, his innovations extend to inflammatory disorders, autoimmune disorders, immunodermatologic disorders, as well as metabolic disorders such as obesity and diabetes. The potential impact of these compounds could be substantial in addressing pressing health issues.

Career Highlights

Alec D. Lebsack has worked with prominent companies in the pharmaceutical sector, notably Janssen Pharmaceutica and Merck Sharp & Dohme Corporation. His experience at these leading organizations has allowed him to focus on cutting-edge research and development, contributing to the innovative landscape of the pharmaceutical industry. His patents are a testament to his dedication to enhancing healthcare solutions.

Collaborations

Throughout his career, Lebsack has collaborated with many talented professionals, including Jing Liu and Wendy Eccles. These collaborations have been instrumental in advancing his research, facilitating the cross-pollination of ideas and expertise within the field. Working alongside such experts underscores Lebsack’s commitment to innovation and excellence.

Conclusion

Alec D. Lebsack's contributions to the field of pharmaceuticals through his extensive patent portfolio showcase his role as an accomplished inventor. His work on small molecule inhibitors stands to impact the treatment of various debilitating diseases, signifying the importance of innovation in medicine. As he continues to collaborate and innovate, Lebsack affirms the critical role that inventors play in advancing healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…